மைக்கேல் முசல்லம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மைக்கேல் முசல்லம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மைக்கேல் முசல்லம் Today - Breaking & Trending Today

Edward Lifesciences Hits Record High on Profit Beat, TAVR Forecast

Edward Lifesciences (
EW) - Get Report shares hit an all-time high Wednesday after the medical devices maker posted Street-beating first quarter earnings as post-COVID procedures gathered past in the waning months of the pandemic.
The Irvine, California-based group generated revenues of $1.22 billion over the first three months of the year, with a bottom life of 54 cents per share, thanks in part to nearly $800 million in sales from its transcatheter aortic valve replacement, or TAVR, unit, which it expects to grow by as much as 20% this year.
TAVR is a minimally invasive heart procedure that is used to repair narrow aortic valves in patients that are often at high risk from complications linked to open-heart surgery. ....

United States , Michael Mussallem , Matt Miksic , Edward Lifesciences , Credit Suisse , Jim Cramer , Health Care Equipment Amp Services , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் முசல்லம் , எட்வர்ட் ஆயுள் அறிவியல் , கடன் ஸ்யூயி , ஜிம் க்ரேமர் , ஆரோக்கியம் பராமரிப்பு உபகரணங்கள் ஆம்ப் சேவைகள் ,

Edwards Lifesciences Q1 Results Beat Street View; Lifts Outlook

Edwards Lifesciences Q1 Results Beat Street View; Lifts Outlook
WASHINGTON (dpa-AFX) - Shares of Edwards Lifesciences Corp. (EW) gained nearly 4% in extended trading session on Tuesday after the company s first-quarter earnings and revenues trumped Wall Street estimates. The company also lifted its earnings guidance for the full year 2021.
The Irvine, California-based company s profit rose to $338.2 million or $0.54 per share from $310.6 million or $0.49 per share last year.
Excluding items, adjusted earnings were $340.4 million or $0.54 per share for the period. Analysts polled by Thomson Reuters expected earnings of $0.47 per share. Analysts estimates typically exclude special items.
First-quarter revenues grew 8% to $1.22 billion from $1.13 billion last year. Analysts had a consensus revenue estimate of $1.16 billion. ....

United States , Michael Mussallem , Thomson Reuters , Edwards Lifesciences Corp , Edwards Lifesciences , Wall Street , Structural Heart , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் முசல்லம் , தாம்சன் ராய்ட்டர்ஸ் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் கார்ப் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , சுவர் தெரு , கட்டமைப்பு இதயம் ,

Edwards Lifesciences Posts Higher 1Q Profit, Sales

Provided by
Dow Jones
By Kimberly Chin
Edwards Lifesciences Corp. posted higher earnings in the first quarter, driven by an increase in sales as the company saw a rise in structural heart procedures during the period.
The medical device company reported earnings of $338.2 million, up from $310.6 million in the comparable period a year earlier. Per-share earnings were 54 cents, up from 49 cents a year ago. Adjusted earnings were 54 cents a share. Analysts were expecting reported earnings of 46 cents a share and adjusted earnings of 47 cents a share, according to a FactSet poll.
Net sales rose to $1.22 billion from $1.13 billion a year earlier. Analysts were looking for $1.16 billion. ....

Michael Mussallem , Kimberly Chin , Dow Jones Company Inc , Edwards Lifesciences Corp , Executive Michael Mussallem , Dow Jones , மைக்கேல் முசல்லம் , கிம்‌பர்லீ கன்னம் , டோ ஜோன்ஸ் நிறுவனம் இன்க் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் கார்ப் , நிர்வாகி மைக்கேல் முசல்லம் , டோ ஜோன்ஸ் ,

4 key trends for medtech in 2021

First published on
The calendar signals a new year, but the medtech industry in 2021 will feel the lingering effects, both positive and negative, from the novel coronavirus pandemic.
With the resurgence of the virus and emergence of new, more contagious strains, COVID-19 will have major impacts on companies much as in 2020, albeit with the benefit of insights gleaned from the historic year and its unprecedented business environment.
Earlier this month, medtech and diagnostics companies gathered virtually to discuss 2021 prospects at J.P. Morgan s annual healthcare conference. Executives painted a mixed picture, with the first half of the year looking bumpier than the second half. ....

United States , John Babbitt , Stephen Macmillan , Alex Nowak , Geoff Martha , Doug Bryant , Robert Ford , Abbott Ford , Joe Almeida , Mike Mahoney , Oxford Immunotec , Jay Saccaro , Michael Mussallem , Abbott Binax , Edwards Lifesciences , Quidel Quickvue , Medtronic Martha , Becton Dickinson , Abbott Laboratories , Preventice Solutions , Boston Scientific , Wall Street , Thermo Fisher Scientific , Somatex Medical , Mesa Biotech , Cantel Medical ,

Abbott, Edwards focus on mitral valve as market projected to rival TAVR

Share it
Transcatheter aortic valve replacement has dominated the structural heart world in recent years, with the market currently valued at about $5 billion and the procedure becoming the primary form of aortic valve replacement in the U.S.
In 2021 and beyond, industry is setting its sights on new heart valve opportunities that could grow to be multiples of the TAVR market: transcatheter mitral valve replacement and repair.
Often in the shadow of the aortic market, mitral has a larger potential patient population, and companies with successful structural heart businesses like Abbott Laboratories and Edwards Lifesciences have secured leading positions in the market as it begins to take off. ....

United States , Matthew Romano , Raj Denhoy , Bernard Zovighian , Michael Mussallem , Joseph Cleveland , Edwards Lifesciences , Abbott Triclip , Jefferie Denhoy , Vijay Kumar , University Of Colorado Anschutz Medical Center , National Center , Abbott Laboratories , Boston Scientific , University Of Michigan , Anschutz Medical Center , Mitral Valve Clinic , After Edwards , ஒன்றுபட்டது மாநிலங்களில் , மேத்யூ ரோமானோ , மைக்கேல் முசல்லம் , ஜோசப் கிளீவ்லேண்ட் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , விஜய் குமார் , பல்கலைக்கழகம் ஆஃப் கொலராடோ அண்சச்சுட்ஸ் மருத்துவ மையம் , தேசிய மையம் ,